Crossmark

HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity

Published Online: 2024-12-02

Published Print: 2025-02

Authors

Navid, Fatemeh

Chen, Liye

Bowness, Paul

Colbert, Robert A. https://orcid.org/0000-0001-6237-4575
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Accepted: 6 November 2024

First Online: 2 December 2024

Competing interests

: R.A.C. has received funding from Novartis, L.C. has received funding from Novartis, P.B. has received institutional research funding from Merck, Benevolent AI, GSK, Regeneron and Novartis.

Document is current